Home › Keryx drug for dialysis patients poised to challenge Genzyme
 

Keywords :   


Keryx drug for dialysis patients poised to challenge Genzyme

2014-12-30 21:36:54| Biotech - Topix.net

Greg Madison assumed the role of COO at Keryx Biopharmaceuticals in February, and today he oversees the 50-employee Boston office. With the its newly-approved drug for kidney dialysis patients now being shipped and available to be prescribed, Keryx Biopharmaceuticals is poised to take on one of Genzyme's drugs with sales of about $600 million.

Tags: drug challenge patients poised

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »